Amsterdam: Europe’s medicines regulator has approved the use of the COVID-19 vaccine jointly developed by US company Pfizer and its German partner BioNTech, putting Europe on course to start inoculations within a week.
European Union countries including Germany, France, Austria and Italy have said they plan to start vaccinations from December 27 as Europe tries to catch up with the United States and Britain, where inoculations began earlier this month.
Having gained the green light from the European Medicines Agency (EMA), the final step is approval by the European Commission, which is expected later on Monday.
“Now we will act fast. I expect a European Commission decision by this evening,” Commission head Ursula von der Leyen wrote on Twitter.